164 related articles for article (PubMed ID: 23832121)
1. Targeted cytolysins synergistically potentiate cytoplasmic delivery of gelonin immunotoxin.
Pirie CM; Liu DV; Wittrup KD
Mol Cancer Ther; 2013 Sep; 12(9):1774-82. PubMed ID: 23832121
[TBL] [Abstract][Full Text] [Related]
2. Convergent potency of internalized gelonin immunotoxins across varied cell lines, antigens, and targeting moieties.
Pirie CM; Hackel BJ; Rosenblum MG; Wittrup KD
J Biol Chem; 2011 Feb; 286(6):4165-72. PubMed ID: 21138845
[TBL] [Abstract][Full Text] [Related]
3. Targeted Delivery of Endosomal Escape Peptides to Enhance Immunotoxin Potency and Anti-cancer Efficacy.
Polli JR; Chen P; Bordeau BM; Balthasar JP
AAPS J; 2022 Mar; 24(3):47. PubMed ID: 35338415
[TBL] [Abstract][Full Text] [Related]
4. Selective killing of squamous carcinoma cells by an immunotoxin that recognizes the EGF receptor.
Ozawa S; Ueda M; Ando N; Abe O; Minoshima S; Shimizu N
Int J Cancer; 1989 Jan; 43(1):152-7. PubMed ID: 2783415
[TBL] [Abstract][Full Text] [Related]
5. Sortase-catalyzed in vitro functionalization of a HER2-specific recombinant Fab for tumor targeting of the plant cytotoxin gelonin.
Kornberger P; Skerra A
MAbs; 2014; 6(2):354-66. PubMed ID: 24492291
[TBL] [Abstract][Full Text] [Related]
6. Design optimization and characterization of Her2/neu-targeted immunotoxins: comparative in vitro and in vivo efficacy studies.
Cao Y; Marks JW; Liu Z; Cheung LH; Hittelman WN; Rosenblum MG
Oncogene; 2014 Jan; 33(4):429-39. PubMed ID: 23376850
[TBL] [Abstract][Full Text] [Related]
7. Single-chain antibody-based immunotoxins targeting Her2/neu: design optimization and impact of affinity on antitumor efficacy and off-target toxicity.
Cao Y; Marks JD; Huang Q; Rudnick SI; Xiong C; Hittelman WN; Wen X; Marks JW; Cheung LH; Boland K; Li C; Adams GP; Rosenblum MG
Mol Cancer Ther; 2012 Jan; 11(1):143-53. PubMed ID: 22090420
[TBL] [Abstract][Full Text] [Related]
8. Cell-targeting fusion constructs containing recombinant gelonin.
Lyu MA; Cao YJ; Mohamedali KA; Rosenblum MG
Methods Enzymol; 2012; 502():167-214. PubMed ID: 22208986
[TBL] [Abstract][Full Text] [Related]
9. Light-controlled endosomal escape of the novel CD133-targeting immunotoxin AC133-saporin by photochemical internalization - A minimally invasive cancer stem cell-targeting strategy.
Bostad M; Olsen CE; Peng Q; Berg K; Høgset A; Selbo PK
J Control Release; 2015 May; 206():37-48. PubMed ID: 25758331
[TBL] [Abstract][Full Text] [Related]
10. Synergistic antitumor activity from two-stage delivery of targeted toxins and endosome-disrupting nanoparticles.
Su X; Yang N; Wittrup KD; Irvine DJ
Biomacromolecules; 2013 Apr; 14(4):1093-102. PubMed ID: 23444913
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate-gelonin conjugate - an inhibitor of MCF-7 cells expressing the dihydrofolate receptor.
Badr M; Kopp C; Theison S; Meyer J; Trommer WE
Biol Chem; 2014 Dec; 395(12):1461-6. PubMed ID: 25205711
[TBL] [Abstract][Full Text] [Related]
12. Challenges associated with the targeted delivery of gelonin to claudin-expressing cancer cells with the use of activatable cell penetrating peptides to enhance potency.
Yuan X; Lin X; Manorek G; Howell SB
BMC Cancer; 2011 Feb; 11():61. PubMed ID: 21303546
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo anti-tumor activities of anti-EGFR single-chain variable fragment fused with recombinant gelonin toxin.
Zhou X; Qiu J; Wang Z; Huang N; Li X; Li Q; Zhang Y; Zhao C; Luo C; Zhang N; Teng X; Chen Z; Liu X; Yu X; Wu W; Wei YQ; Li J
J Cancer Res Clin Oncol; 2012 Jul; 138(7):1081-90. PubMed ID: 22392077
[TBL] [Abstract][Full Text] [Related]
14. Construction and characterization of novel, recombinant immunotoxins targeting the Her2/neu oncogene product: in vitro and in vivo studies.
Cao Y; Marks JD; Marks JW; Cheung LH; Kim S; Rosenblum MG
Cancer Res; 2009 Dec; 69(23):8987-95. PubMed ID: 19934334
[TBL] [Abstract][Full Text] [Related]
15. Photochemical internalisation increases the cytotoxic effect of the immunotoxin MOC31-gelonin.
Selbo PK; Sivam G; Fodstad O; Sandvig K; Berg K
Int J Cancer; 2000 Sep; 87(6):853-9. PubMed ID: 10956397
[TBL] [Abstract][Full Text] [Related]
16. Humanized M195 monoclonal antibody conjugated to recombinant gelonin: an anti-CD33 immunotoxin with antileukemic activity.
Pagliaro LC; Liu B; Munker R; Andreeff M; Freireich EJ; Scheinberg DA; Rosenblum MG
Clin Cancer Res; 1998 Aug; 4(8):1971-6. PubMed ID: 9717827
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of the cytotoxic effect of anti-carcinoembryonic antigen immunotoxins by adenovirus and carboxylic ionophores.
Griffin TW; Childs LR; FitzGerald DJ; Levin LV
J Natl Cancer Inst; 1987 Oct; 79(4):679-85. PubMed ID: 3498854
[TBL] [Abstract][Full Text] [Related]
18. Molecular tumor targeting of gelonin by fusion with F3 peptide.
Ham SH; Min KA; Shin MC
Acta Pharmacol Sin; 2017 Jun; 38(6):897-906. PubMed ID: 28414205
[TBL] [Abstract][Full Text] [Related]
19. A novel Carcinoembryonic Antigen (CEA)-Targeted Trimeric Immunotoxin shows significantly enhanced Antitumor Activity in Human Colorectal Cancer Xenografts.
Lázaro-Gorines R; Ruiz-de-la-Herrán J; Navarro R; Sanz L; Álvarez-Vallina L; Martínez-Del-Pozo A; Gavilanes JG; Lacadena J
Sci Rep; 2019 Aug; 9(1):11680. PubMed ID: 31406218
[TBL] [Abstract][Full Text] [Related]
20. Comparative cytotoxicity and pharmacokinetics of antimelanoma immunotoxins containing either natural or recombinant gelonin.
Rosenblum MG; Marks JW; Cheung LH
Cancer Chemother Pharmacol; 1999; 44(4):343-8. PubMed ID: 10447583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
